Viscosupplementation is one of the treatment procedures to relieve Osteoarthritis. Hyaluronic acid is found in synovial fluids surrounding the joints. It acts as a lubricating agent, enabling smooth movement of the bones. The Hyaluronic Acid Viscosupplementation market is segmented based on the course of treatment, which is again sub-segmented based on the different doses of injections. The market is also categorized based on anatomy and end user. The Hyaluronic Acid Viscosupplementation market is estimated to grow at a CAGR of 6.36% through 2023.  

Hyaluronic Acid Viscosupplementation helps in improving the mobility of the joints and improves the comfort level during any activity. On the basis of course of treatment, the single injection segment dominates the market and is estimated to grow at a CAGR of 7.71% through 2023. Based on anatomy, the Knee segment is projected to grow at the highest CAGR during the forecast period.  The North America Hyaluronic Acid Viscosupplementation market is forecast to grow at a CAGR of 6.56% through 2023. However, Asia-Pacific is estimated to dominate the market during the forecast period due to the rising elderly population.   

The Hyaluronic Acid Viscosupplementation Market is largely driven by the growing awareness among patients about the new treatments of osteoarthritis. Rising prevalence and incidence of osteoarthritis is accelerating the growth of the market. Rising obese population globally and increasing geriatric population are also major factors for the growth of the market. Growing awareness about the benefits of minimally invasive surgical procedures for osteoarthritis is one of the key factors that drive the hyaluronic acid viscosupplement market’s growth.

Lack of safety and efficacy associated with viscosupplementation products pose major challenges for the market. Complex Regulatory processes regarding the products of Viscosupplementation may slow down the market because it takes a long time to get approval for any product from the regulatory bodies. The reimbursement policies associated with the treatment varies from one country to another, and thus, this can also pose challenges for the market.   

Hyaluronic Acid Viscosupplementation Market Research Scope:-

The base year of the study is 2017, with forecast done up to 2023. The study presents a thorough analysis of the competitive landscape, taking into account the market shares of the leading companies. It also provides information on volume shipments. These provide the key market participants with the necessary business intelligence and help them understand the future of the Hyaluronic Acid Viscosupplementation market. The assessment includes the forecast, an overview of the competitive structure, the market shares of the competitors, as well as the market trends, market demands, market drivers, market challenges, and product analysis. The market drivers and restraints have been assessed to fathom their impact over the forecast period. This report further identifies the key opportunities for growth while also detailing the key challenges and possible threats. The key areas of focus include the types of treatment, by anatomy and vaccines by disease indication.

By Course of Treatment: Single Injections, Multiple Injections

By Anatomy: Knee Osteoarthritis, Hip Osteoarthritis, Ankle Osteoarthritis, and Shoulder Osteoarthritis.

By End User: Hospitals, Clinics and Ambulatory Surgical Centers.  

The Hyaluronic Acid Viscosupplementation Market report also analyzes the major geographic regions for the market as well as the major countries for the market in these regions. The regions and countries covered in the study include:

Labrha International launched HAPPYMINI for the treatment of Temporo-Mandibular Osteoarthritis. Labrha provides a complete range of new and innovative viscosupplement.

Some of the other key players in this market are LG Chem Ltd, Bioventus Inc., Sanofi Genzyme, Anika Therapeutics, Seikagaku Corporation and many others.